DELRAY BEACH, Fla., April 23, 2025 /PRNewswire/ -- The global Latin America Advanced Wound Care Market, valued at US$285.9 million in 2024, is forecasted to grow at a robust CAGR of 9.8%, reaching US$312.8 million in 2025 and an impressive US$498.2 million by 2030. The increasing prevalence of diabetes, the rising cases of traumatic & burn injuries, and the expansion of the geriatric population along with age-associated syndromes are the key factors driving market growth. Additionally, the growth potential of emerging countries is a critical element contributing to market development. As these countries in the LATAM region experience economic growth and rising improvements in healthcare infrastructure, the demand for advanced wound care products is also set to increase. These factors collectively create a promising environment for market growth, with both local & international companies seeking to capitalize on the demand for advanced wound care solutions.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221030335
Browse in-depth TOC on 'Latin America Advanced Wound Care Market'
186 - Tables
47 - Figures
221 - Pages
By Based on wound type, the LATAM advanced wound care market is segmented into acute wounds and chronic wounds. The chronic wounds segment accounted for the largest share of the market in 2024. The large share of this segment can be attributed to the rising number of traffic accidents, workplace injuries, and other trauma-related incidents that require immediate medical care. The increasing number of surgical procedures is also expected to drive the demand for post-operative wound care, fuelling this segment's market growth.
By end user, the LATAM advanced wound care market is divided into hospitals & clinics, ambulatory surgery centers, home care settings, and other end users. In 2024, the hospitals & clinics segment accounted for the largest share of the market. The rising incidence of pressure ulcers and post-operative wounds stimulates the need for advanced wound care products in hospitals & clinics. Hospital visits for wound care have also increased due to the expanding geriatric population and the associated rise in diabetic foot ulcers and pressure ulcers. The efficiency of hospitals & clinics with efficient staff, established protocols, and the availability of several advanced wound care products are expected to contribute to market growth.
By geography, the LATAM advanced wound care market is segmented into Brazil, Mexico, Colombia, Argentina, Peru, Chile, and the rest of Latin America. Brazil accounted for the largest market share of 42.3% in the LATAM advanced wound care market. The increasing prevalence of diabetes, the rising number of surgical procedures, and the presence of leading LATAM advanced wound care manufacturing companies in Brazil contribute to market growth. Brazil has also observed a rise in obesity cases and road accidents, which are expected to fuel market adoption of advanced wound care products.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=221030335
Prominent players in the LATAM advanced wound care market include Solventum (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Mölnlycke AB (Sweden), Essity Aktiebolag (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Coloplast Group (Denmark), Integra LifeSciences Corporation (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), and AVERY DENNISON CORPORATION (US).
Solventum (US):
In April 2024, after its spin-off from 3M, Solventum began its operations as a standalone company. Although the firm profited from 3M's assets and reputation previously, it is now focused on creating its own brand identity. Solventum creates, produces, and markets various products to satisfy customer demands and establish a brand image. The company primarily operates through four business segments: MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration. Solventum's integration of material science and digital capabilities is expected to strengthen its competitive edge, improving its clinical & economic outcomes for healthcare providers.
Mölnlycke AB (Sweden)
Mölnlycke AB has a global presence owing to its vast distribution network. The firm has a presence across LATAM, including Argentina, Colombia, Brazil, and Mexico. The company expands its presence via inorganic strategies to enhance business operations. For instance, in October 2024, Mölnlycke acquired P.G.F. Industry Solutions (Austria), the manufacturer of Granudacyn wound cleansing & moistening solutions. The acquisition strengthens Mölnlycke's wound care portfolio and expands the distribution of Granudacyn, which is currently available in over 50 countries. Similarly, in October 2024, the company partnered with Transdiagen (UK) to explore novel wound gene signatures for wound care product innovation. The collaboration provides Mölnlycke access to Transdiagen's models to generate insights into biological wound treatment solutions and enhance evidence-based product development.
Coloplast Group (Denmark)
Coloplast is a leading provider of LATAM advanced wound care products. The firm offers various medical products to support patient care and improve treatment outcomes. With a robust product portfolio, Coloplast is one of the leading players in the LATAM advanced wound care market. The company operates through five segments: Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology, and Voice & Respiratory Care. The company provides wound care products through its Advanced Wound Care segment. The Wound & Skin Care subsegment offers hydrocolloid dressings under the Comfeel brand while foam dressings under the Biatain brand. Coloplast's products are provided in hospitals and through wholesalers and retailers.
For more information, Inquire Now!
Related Reports:
Get access to the latest updates on Latin America Advanced Wound Care Companies and Latin America Advanced Wound Care Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Share this article